References:
1. Haylen BT, De Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourology and Urodynamics: Official Journal of the International Continence Society. 2010;29(1):4-20.
2. McDougal WS, Wein AJ, Kavoussi LR, Partin AW, Peters CA. Campbell-Walsh Urology 11th Edition Review E-Book: Elsevier Health Sciences; 2015.
3. Shirvan MK, Alamdar DH, Ghorifi A, Rahimi HR. A novel treatment for urethrovaginal fistula: autologous platelet-rich–plasma injection and platelet-rich–fibrin-glue interposition. Journal of Gynecologic Surgery. 2013;29(5):268-70.
4. Gomelsky A, Dmochowski RR. Treatment of mixed urinary incontinence. Central European journal of urology. 2011;64(3):120.
5. Committee on Practice B-G, the American Urogynecologic S. ACOG Practice Bulletin No. 155 Summary: Urinary Incontinence in Women. Obstet Gynecol. 2015;126(5):1120-2.
6. Labrie J, Berghmans BL, Fischer K, Milani AL, Van Der Wijk I, Smalbraak DJ, et al. Surgery versus physiotherapy for stress urinary incontinence. New England Journal of Medicine. 2013;369(12):1124-33.
7. Kulseng-Hanssen S, Husby H, Schiøtz HA. Follow-up of TVT operations in 1,113 women with mixed urinary incontinence at 7 and 38 months. International Urogynecology Journal. 2008;19(3):391-6.
8. Kuo HC. Botulinun A toxin urethral sphincter injection for neurogenic or nonneurogenic voiding dysfunction. Tzu Chi Medical Journal. 2016 Sep 1;28(3):89-93
9. PHELAN MW, FRANKS M, SOMOGYI GT, YOKOYAMA T, FRASER MO, LAVELLE JP, YOSHIMURA N, CHANCELLOR MB. Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. The Journal of urology. 2001 Apr;165(4):1107-10.
10. Shirvan MK, Alamdari DH, Mahboub MD, Ghanadi A, Rahimi HR, Seifalian AM. A novel cell therapy for stress urinary incontinence, short‐term outcome. Neurourology and urodynamics. 2013 Apr;32(4):377-82.